Policy Activity
For decades, rising costs of health care, health insurance, and prescription drugs have been a major concern for American consumers, caregivers,…
Aimed Alliance recently sent a letter urging the Virginia House Labor and Commerce Committee to reconsider House Bill 483, which…
Aimed Alliance is pleased to share two new resources on prescription drug affordability boards (PDABs). PDABs are established at the…
Gold card laws exempt healthcare providers from prior authorization if they have a high approval rate, reducing delays in patient…
Aimed Alliance, the National Bleeding Disorders Foundation and the Hemophilia Alliance, released a new resource, “Protecting Consumers from Unfair and…
On December 5, 2025, Aimed Alliance’s Counsel, Michael Barnes, published a new opinion piece titled “Trump Administration Took Decisive Action…
Aimed Alliance has released a new fact sheet explaining the role of the U.S. Trade Representative (USTR) in shaping international…
A new article by Fierce Healthcare titled “A new wave of middlemen offers ‘alternative funding’ for specialty drugs. Patients bear…